Medicamen Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 854.85 million compared to INR 666.2 million a year ago. Revenue was INR 864.14 million compared to INR 681.07 million a year ago. Net income was INR 56.91 million compared to INR 71.9 million a year ago. Basic earnings per share from continuing operations was INR 4.29 compared to INR 5.68 a year ago. Diluted earnings per share from continuing operations was INR 4.29 compared to INR 5.68 a year ago.